Skip to main content
Journal cover image

Safety evaluation of carbon tetrafluoride as an inert hyperbaric breathing gas in Sprague-Dawley rats.

Publication ,  Journal Article
Makowski, MS; Sproul, C; Swartz, C; Everitt, JI; Knaus, DA; Wilbur, JC; Moon, RE
Published in: Toxicol Appl Pharmacol
June 1, 2022

Carbon tetrafluoride (CF4) is an inert gas with higher molecular weight and lower water solubility than commonly used hyperbaric breathing gases. These inert gas properties decrease time required to decompress and avoid decompression sickness after deep dives. To assess CF4 toxicity, Sprague-Dawley rats were exposed to 8 atm absolute (ATA) air (10 males, 10 females) or 8 ATA 79% CF4/21% O2 (25 males, 25 females). Exposures were 30 min daily for 5 days. Rat behavior was normal throughout the testing period. There were no gross or microscopic pathology abnormalities following repeat dose exposure. Male body weight trends were similar between groups. Female body weight trends were 0.5 ± 0.8% day-1 for hyperbaric air exposure and - 0.2 ± 0.8% day-1 for hyperbaric CF4 exposure (P = 0.01) but remained within literature cited norms. Organ weights and hematologic indices remained within or near literature normal ranges. Clinical chemistry panels showed no signs of toxicity in renal or hepatic biomarkers. Polychromatic erythrocyte micronucleus frequency showed no chromosomal damage. Comet assay showed no DNA damage in lung tissue. Females exposed to CF4 had 2.5 times greater percent tail DNA in liver tissue than controls (P = 0.009). However this result remained within the normal range of local negative controls. A bacterial reverse mutation assay with exposure to 1 ATA 79% CF4/21% O2 for 72 h was nonmutagenic in four strains of Salmonella typhimurium and one strain of Escherichia coli. Overall, there was no evidence that CF4 caused organ toxicity or genetic toxicity.

Duke Scholars

Published In

Toxicol Appl Pharmacol

DOI

EISSN

1096-0333

Publication Date

June 1, 2022

Volume

444

Start / End Page

116023

Location

United States

Related Subject Headings

  • Toxicology
  • Rats, Sprague-Dawley
  • Rats, Inbred F344
  • Rats
  • Male
  • Liver
  • Fluorocarbons
  • Female
  • Body Weight
  • Animals
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Makowski, M. S., Sproul, C., Swartz, C., Everitt, J. I., Knaus, D. A., Wilbur, J. C., & Moon, R. E. (2022). Safety evaluation of carbon tetrafluoride as an inert hyperbaric breathing gas in Sprague-Dawley rats. Toxicol Appl Pharmacol, 444, 116023. https://doi.org/10.1016/j.taap.2022.116023
Makowski, Matthew S., Christopher Sproul, Carol Swartz, Jeffrey I. Everitt, Darin A. Knaus, Jed C. Wilbur, and Richard E. Moon. “Safety evaluation of carbon tetrafluoride as an inert hyperbaric breathing gas in Sprague-Dawley rats.Toxicol Appl Pharmacol 444 (June 1, 2022): 116023. https://doi.org/10.1016/j.taap.2022.116023.
Makowski MS, Sproul C, Swartz C, Everitt JI, Knaus DA, Wilbur JC, et al. Safety evaluation of carbon tetrafluoride as an inert hyperbaric breathing gas in Sprague-Dawley rats. Toxicol Appl Pharmacol. 2022 Jun 1;444:116023.
Makowski, Matthew S., et al. “Safety evaluation of carbon tetrafluoride as an inert hyperbaric breathing gas in Sprague-Dawley rats.Toxicol Appl Pharmacol, vol. 444, June 2022, p. 116023. Pubmed, doi:10.1016/j.taap.2022.116023.
Makowski MS, Sproul C, Swartz C, Everitt JI, Knaus DA, Wilbur JC, Moon RE. Safety evaluation of carbon tetrafluoride as an inert hyperbaric breathing gas in Sprague-Dawley rats. Toxicol Appl Pharmacol. 2022 Jun 1;444:116023.
Journal cover image

Published In

Toxicol Appl Pharmacol

DOI

EISSN

1096-0333

Publication Date

June 1, 2022

Volume

444

Start / End Page

116023

Location

United States

Related Subject Headings

  • Toxicology
  • Rats, Sprague-Dawley
  • Rats, Inbred F344
  • Rats
  • Male
  • Liver
  • Fluorocarbons
  • Female
  • Body Weight
  • Animals